Clinitech Laboratory Limited - healthcare in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L85195MH2010PLC201078 Incorporated 19 March 2010 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Listed - BSE: 544220 Public Limited Company healthcare MSME · Small
Market Cap
₹7.79 Cr
CTLLAB · BSE
Share Price
₹32.05
-6.15% today
Revenue
₹9.49 Cr
FY 2025-26 · +15.3% YoY
EBITDA
₹1.00 Cr
Margin 10.5%
Net Profit
₹0.43 Cr
FY 2025-26 · +48.3% YoY
P/E (TTM)
17.7x
P/B 0.8x
ROE
4.5%
ROCE 6.9%
Debt / Equity
0.03
Interest cover 14.3x

About Clinitech Laboratory Limited

Data last updated:

Clinitech Laboratory Limited is a public limited company based in Navi Mumbai, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 19 March 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L85195MH2010PLC201078. It is a listed company as per MCA records. Its shares are listed on BSE: 544220.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.28 Cr. It is led by directors including Jagdish Umakant Nayak (Managing Director) and Jyoti Jagdish Nayak (Whole-Time Director).

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Al – 1/545 Sector 16 Airoli Opposite Radhikabai Meghe Vidyalaya, Navi Mumbai, Maharashtra, India – 400708.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹9.49 Cr, a growth of 15.3% compared to the previous year. For the same year it recorded a net profit of ₹43 Lakh (net margin 4.5%) and EBITDA of ₹1 Cr (EBITDA margin 10.5%). The net worth stands at ₹9.25 Cr (up 4.8% YoY). Total assets are valued at ₹10.04 Cr (up 11.2% YoY).

The company has about 13 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Clinitech Laboratory. As per MCA filings, the company has open charges of ₹1.02 Cr and satisfied charges of ₹1.22 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 17 deals on record (15 market trades, 1 ipo, 1 funding round), with disclosed funding of ₹68.4 Lakh; the latest was in April 2026. The company has 4 MSME Form 1 returns on record between 2019 and 2024, listing 39 overdue payments to 9 micro and small suppliers.

Clinitech Laboratory Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0082699). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ctllab.in.

Company details

CIN L85195MH2010PLC201078
Registration Number 201078
Incorporation Date 19 March 2010
ROC Mumbai
Listing Status Listed - Listed on BSE (544220)
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0082699

CIN history

Clinitech Laboratory has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85195MH2010PLC201078, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85195MH2010PLC201078Current
U85195MH2010PLC201078Previous
U85195MH2010PTC201078Previous

Recognitions & Rankings of Clinitech Laboratory

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-33-0082699

Contact details

Clinitech Laboratory Limited's registered office is in Navi Mumbai, Maharashtra.

  • Social Media
  • Registered Address
    Al – 1/545 Sector 16 Airoli Opposite Radhikabai Meghe Vidyalaya, Navi Mumbai, Maharashtra, India – 400708
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Clinitech Laboratory Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Clinitech Laboratory operates one associated brand: Clinitech Laboratory. Each brand links to its own profile.

BrandDescriptionWebsite
Pathology lab services are operated through a chain in India.clinitechlab.com

Business activity

The main business activity of Clinitech Laboratory is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ2Medical and dental practice, Nursing, pathology, blood bank services, etc.

To see the full business activity and turnover split of Clinitech Laboratory Limited, buy the company report.

Financials of Clinitech Laboratory Limited

FY 2025-26 filings available

Clinitech Laboratory Limited reported revenue of ₹9.49 Cr (up 15.3% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹9.49 Cr
+15.3% YoY
EBITDA
₹1.00 Cr
+22.0% YoY
Profit After Tax
₹0.43 Cr
+48.3% YoY
Net Worth
₹9.25 Cr
+4.8% YoY
Total Assets
₹10.04 Cr
+11.2% YoY
Total Debt
₹0.54 Cr

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25
Income statement
Revenue9.498.23
Revenue growth+15.3%-
EBITDA1.000.82
EBITDA margin+10.5%+10.0%
Profit before tax0.610.54
Net profit0.430.29
Net profit margin+4.5%+3.5%
EPS (₹)1.831.73
Balance sheet
Total assets10.049.03
Net worth9.258.83
Total debt0.540.00
Cash & bank2.113.07
Net working capital6.235.65
Cash flow
Cash from operations(0.79)(0.88)
Cash from investing(0.68)(0.73)
Cash from financing0.513.98
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income statement
Revenue9.488.236.406.356.384.55
Revenue growth+15.2%+28.6%+0.8%-0.5%+40.2%-
EBITDA1.000.821.001.361.060.83
EBITDA margin+10.6%+10.0%+15.6%+21.4%+16.6%+18.2%
Profit before tax0.610.540.510.860.690.54
Net profit0.430.290.370.610.500.37
Net profit margin+4.5%+3.5%+5.8%+9.6%+7.8%+8.1%
EPS (₹)1.851.732.214.093.426.04
Balance sheet
Total assets9.869.034.615.022.852.02
Net worth9.258.833.552.381.851.39
Total debt0.360.000.871.030.890.54
Cash & bank2.063.070.700.780.100.32
Net working capital6.315.651.700.950.550.92
Cash flow
Cash from operations(0.90)(0.88)(1.28)1.250.960.38
Cash from investing(0.44)(0.73)0.75(0.65)(1.47)0.54
Cash from financing0.333.980.450.090.29(0.88)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 21 Nov 2026
ParticularsFY 2025-26FY 2024-25
Revenue9.498.23
Revenue growth+15.3%-
Other income0.190.23
Total expenses8.497.41
Employee cost2.602.38
EBITDA1.000.82
EBITDA margin+10.5%+10.0%
Depreciation0.510.45
Interest0.070.06
Profit before tax0.610.54
Tax0.180.16
Net profit0.430.29
Net profit margin+4.5%+3.5%
EPS (₹)1.831.73
ParticularsFY 2025-26FY 2024-25
Equity & liabilities
Share capital2.282.28
Reserves & surplus6.976.55
Shareholders' funds (net worth)9.258.83
Minority interest0.000.00
Secured loans0.540.00
Unsecured loans0.000.00
Total debt0.540.00
Total liabilities10.049.03
Assets
Gross block5.905.33
Net block2.182.12
Capital work in progress1.251.01
Investments0.070.07
Inventories0.730.53
Sundry debtors1.851.54
Cash & bank balances2.113.07
Loans & advances2.682.32
Total current assets7.377.46
Total current liabilities1.141.81
Net working capital6.235.65
Total assets10.049.03
ParticularsFY 2025-26FY 2024-25
Opening cash3.070.70
Net cash from operating activities(0.79)(0.88)
Net cash from investing activities(0.68)(0.73)
Net cash from financing activities0.513.98
Net change in cash(0.96)2.37
Closing cash2.113.07
ParticularsFY 2025-26FY 2024-25
Growth
Sales growth+15.3%-
EBITDA growth+22.0%-
PBT growth+13.0%+9997.0%
Net income growth+48.3%-
Profitability & leverage
Net income margin+4.5%+4.6%
Return on capital employed+6.9%+6.0%
Return on net worth+4.5%+3.4%
Debt / equity0.030.00
Long-term debt / equity0.030.00
Interest cover14.2916.22
Efficiency & per share
Fixed asset turnover1.691.54
Inventory turnover15.0615.53
Debtors turnover5.605.34
EPS (₹)1.831.73
Dividend per share (₹)0.000.00
Book value per share (₹)40.5238.69
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Revenue9.488.236.406.356.384.55
Revenue growth+15.2%+28.6%+0.8%-0.5%+40.2%-
Other income0.190.230.040.020.070.04
Total expenses8.487.415.404.995.323.72
Employee cost2.602.381.921.551.380.92
EBITDA1.000.821.001.361.060.83
EBITDA margin+10.6%+10.0%+15.6%+21.4%+16.6%+18.2%
Depreciation0.510.450.440.450.380.25
Interest0.070.060.090.070.060.08
Profit before tax0.610.540.510.860.690.54
Tax0.180.160.130.250.190.14
Net profit0.430.290.370.610.500.37
Net profit margin+4.5%+3.5%+5.8%+9.6%+7.8%+8.1%
EPS (₹)1.851.732.214.093.426.04
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Equity & liabilities
Share capital2.282.281.681.501.500.67
Reserves & surplus6.976.551.870.880.350.72
Shareholders' funds (net worth)9.258.833.552.381.851.39
Secured loans0.360.000.530.590.640.48
Unsecured loans0.000.000.340.440.250.06
Total debt0.360.000.871.030.890.54
Total liabilities9.869.034.615.022.852.02
Assets
Gross block5.905.334.473.653.522.45
Net block2.182.121.711.331.650.84
Capital work in progress0.991.010.940.560.410.08
Investments0.080.070.072.020.140.09
Inventories0.730.530.280.140.160.09
Sundry debtors1.851.540.600.490.360.56
Cash & bank balances2.063.070.700.780.100.32
Loans & advances2.722.321.120.550.760.66
Total current assets7.367.462.701.961.381.63
Total current liabilities1.051.811.001.010.830.71
Net working capital6.315.651.700.950.550.92
Total assets9.869.034.615.022.852.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Opening cash3.070.700.780.100.320.28
Net cash from operating activities(0.90)(0.88)(1.28)1.250.960.38
Net cash from investing activities(0.44)(0.73)0.75(0.65)(1.47)0.54
Net cash from financing activities0.333.980.450.090.29(0.88)
Net change in cash(1.01)2.37(0.08)0.68(0.22)0.04
Closing cash2.063.070.700.780.100.32
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Growth
Sales growth+15.2%+28.6%+0.8%-0.5%+40.2%-
EBITDA growth+22.0%-18.0%-26.5%+28.3%+27.7%-
PBT growth+13.0%+5.9%-40.7%+24.6%+27.8%+9997.0%
Net income growth+48.3%-21.6%-39.3%+22.0%+35.1%-
Revenue CAGR (3Y)+14.3%+8.9%+12.0%---
EBITDA CAGR (3Y)-9.7%-8.2%+6.4%---
Profitability & leverage
Net income margin+4.5%+4.6%+5.9%+9.6%+7.8%+8.8%
Return on capital employed+7.1%+7.9%+12.3%+23.6%+31.2%+30.7%
Return on net worth+4.7%+4.9%+12.5%+28.8%+31.5%+28.8%
Debt / equity0.020.070.320.450.440.38
Long-term debt / equity0.020.020.090.150.260.34
Interest cover14.2916.2216.077.698.8213.79
Efficiency & per share
Fixed asset turnover1.691.681.581.772.141.86
Inventory turnover15.0520.3230.4842.3351.0450.56
Debtors turnover5.597.6911.7414.9413.878.13
EPS (₹)1.851.732.214.093.426.04
Dividend per share (₹)0.000.000.000.000.000.00
Book value per share (₹)40.5438.6921.1215.8712.3220.86

To see the full year-wise statements and ratios of Clinitech Laboratory Limited, buy the company report.

Board of directors of Clinitech Laboratory Limited

Clinitech Laboratory has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashutosh Jagdish NayakDirector31 Jan 20224 Years 9 MonthsCurrent
Jagdish Umakant NayakManaging Director19 Mar 201016 Years 8 MonthsCurrent
Jyoti Jagdish NayakWhole-Time Director19 Mar 201016 Years 8 MonthsCurrent
Balu Laxman KumbharkarDirector19 Jun 20233 Years 5 MonthsCurrent
Ravikant Moreshwar MhatreDirector19 Jun 20233 Years 5 MonthsCurrent
Smita Arjun PatilDirector19 Jun 20233 Years 5 MonthsCurrent

Charges & borrowings

Open charges
₹1.02 Cr
Satisfied charges
₹1.22 Cr
Breakdown by lending institutions
Others₹1.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Aug 2026101397094Others₹31.5 LakhOpen
31 Jul 2026101369826Others₹28 LakhOpen
05 Feb 2026101232728Others₹22.5 LakhOpen
09 Apr 2025101118096Others₹20 LakhOpen
28 Dec 2021100520583Others₹90 LakhSatisfied

To see the full charge records of Clinitech Laboratory Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Clinitech Laboratory Limited has 17 deals on record (15 market trades, 1 ipo, 1 funding round), with disclosed funding of ₹68.4 Lakh; the latest was in April 2026.

Total deals
17
Market trades
15
IPO
1
Funding round
1
Disclosed funding
₹68.4 Lakh

Deals on record (5 of 17)

WhenDealAmountParties
Aug 2025Market trade₹10.2 LakhBuyer: Bonanza Portfolio (Ifsc) Private Limited
Seller: Bonanza Portfolio (Ifsc) Private Limited , an individual
Aug 2024Market trade₹12.7 LakhSeller: Multiplier Share and Stock Advisors Private Limited
Aug 2024Market trade₹13.4 LakhSeller: Multiplier Share and Stock Advisors Private Limited
Aug 2024Market trade₹26.6 LakhBuyer: Multiplier Share and Stock Advisors Private Limited
Aug 2024Market trade₹26.2 LakhBuyer: an individual
Seller: Virtuous Capital Limited

To see the full deal history of Clinitech Laboratory Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Clinitech Laboratory Limited has 4 MSME Form 1 returns on record between 2019 and 2024, listing 39 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 9)

SupplierAmount dueDue sinceReported on
an individual supplier
Analog Healthcare Private Limited
Laxmi Diagnostic
Lilac Insights Private Limited
Lifesys Biomedical

To see the full MSME payment records of Clinitech Laboratory Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

No GST registration is on our record for Clinitech Laboratory Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Clinitech Laboratory Limited has 12 board changes on record since 2010: 6 appointments and 6 cessations. The latest: Ashutosh Jagdish Nayak ceased to be Director on 29 Sep 2023.

Charges
A charge registered on 28 Dec 2021 via Charge ID 100520583 with Others was fully satisfied on 28 Sep 2026.
Charges
A charge with Others amounted to Rs. 0.32 Cr with Charge ID 101397094 was registered on 27 Aug 2026.
Charges
A charge with Others amounted to Rs. 0.28 Cr with Charge ID 101369826 was registered on 31 Jul 2026.
Filing
Clinitech Laboratory Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 0.23 Cr with Charge ID 101232728 was registered on 05 Feb 2026.
AGM
Clinitech Laboratory Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 101118096 was registered on 09 Apr 2025.
Ceased
Ashutosh Jagdish Nayak ceased to be Director.
Ceased
Balu Laxman Kumbharkar ceased to be Additional Director.
Ceased
Jagdish Umakant Nayak ceased to be Director.
Ceased
Jyoti Jagdish Nayak ceased to be Director.
Ceased
Ravikant Moreshwar Mhatre ceased to be Additional Director.

13 earlier events are in the company report.

Frequently asked questions

Clinitech Laboratory is an active public limited company based in Navi Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 19 March 2010 (16+ years old) and is registered under CIN L85195MH2010PLC201078. Listed on BSE: 544220.

Clinitech Laboratory reported revenue of ₹9.49 Cr for FY 2025-26 (up 15.3% YoY) based on consolidated financials.

Clinitech Laboratory has 6 current directors:

The latest financial statements of Clinitech Laboratory on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Clinitech Laboratory is L85195MH2010PLC201078. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Clinitech Laboratory is a listed company as per MCA records. Its shares are listed on BSE (code: 544220).

Clinitech Laboratory has 1 court case on record: 1 filed by the company. 1 is pending.

Clinitech Laboratory was incorporated on 19 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.

Clinitech Laboratory has 17 deals on record (15 market trades, 1 ipo, 1 funding round), with disclosed funding of ₹68.4 Lakh; the latest was in April 2026.

Ashutosh Jagdish Nayak ceased to be Director on 29 Sep 2023. Balu Laxman Kumbharkar ceased to be Additional Director on 29 Sep 2023. Jagdish Umakant Nayak ceased to be Director on 29 Sep 2023. Clinitech Laboratory has 12 board changes on record in total.

Yes, Clinitech Laboratory is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0082699).